1,935
Views
1
CrossRef citations to date
0
Altmetric
Full Length Article

Preparation and properties of Pue-loaded HA-ADH-PS nanomicelles

, , , , , , & show all
Pages 1-12 | Received 14 Oct 2020, Accepted 03 Dec 2020, Published online: 17 Jan 2021

References

  • Xi J, Guo R. Acid-base equilibrium of puerarin in CTAB micelles. J Pharma Biomed Anal. 2007 Jan 4;43:111–118.
  • Gao Y, Wang X, He C. An isoflavonoid-enriched extract from Pueraria lobata (kudzu) root protects human umbilical vein endothelial cells against oxidative stress induced apoptosis. J ethnopharmacology. 2016 Dec 4;193:524–530.
  • Liu XY, Ding YX, Zhao BJ, et al. In vitro and in vivo evaluation of puerarin-loaded PEGylated mesoporous silica nanoparticles. Drug Dev Ind Pharm. 2016 Dec;42:2031–2037.
  • Li Y, Pan WS, Chen SL, et al. Pharmacokinetic, tissue distribution, and excretion of puerarin and puerarin-phospholipid complex in rats. Drug Dev Ind Pharm. 2006 Apr;32:413–422.
  • Luo CF, Yuan M, Chen MS, et al. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration. Int J Pharm. 2011 May 30;410:138–144.
  • Ye H, Yuan S, Cong X. Biotransformation of puerarin into 3′-hydroxypuerarin by Trichoderma harzianum NJ01. Enzyme Microb Technol. 2007;40:594–597.
  • Guo J, Xing X, Lv N, et al. Therapy for myocardial infarction: in vitro and in vivo evaluation of puerarin-prodrug and tanshinone co-loaded lipid nanoparticulate system. Biomed Pharmacother. 2019 Dec;120:109480.
  • Chen AZ, Li Y, Chau FT, et al. Microencapsulation of puerarin nanoparticles by poly(l-lactide) in a supercritical CO(2) process. Acta Biomater. 2009 Oct;5:2913–2919.
  • Zhong L, Liu YY, Xu L, et al. Exploring the relationship of hyaluronic acid molecular weight and active targeting efficiency for designing hyaluronic acid-modified nanoparticles. Asian J Pharm Sci. 2019 Sep;14:521–530.
  • Rao NV, Yoon HY, Han HS, et al. Recent developments in hyaluronic acid-based nanomedicine for targeted cancer treatment. Expert Opin Drug Deliv. 2016 Feb 1;13:239–252.
  • Choi KY, Chung H, Min KH, et al. Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials. 2010 Jan;31:106–114.
  • Necas J, Bartosikova L, Brauner P, et al. Hyaluronic acid (hyaluronan): a review. Vet Med-Czech. 2008 Aug;53:397–411.
  • Ye X, Li X, Shen YQ, et al. Self-healing pH-sensitive cytosine- and guanosine-modified hyaluronic acid hydrogels via hydrogen bonding. Polymer. 2017 Jan 13;108:348–360.
  • Fiorica C, Palumbo FS, Pitarresi G, et al. Hyaluronic acid and beta cyclodextrins films for the release of corneal epithelial cells and dexamethasone. Carbohyd Polym. 2017 Jun 15;166:281–290.
  • Li J, Shin GH, Chen XG, et al. Modified curcumin with hyaluronic acid: combination of pro-drug and nano-micelle strategy to address the curcumin challenge. Food Res Int. 2015 Mar;69:202–208.
  • Feng Q, Lin S, Zhang KY, et al. Sulfated hyaluronic acid hydrogels with retarded degradation and enhanced growth factor retention promote hMSC chondrogenesis and articular cartilage integrity with reduced hypertrophy. Acta Biomater. 2017 Apr 15;53:329–342.
  • Nishiyama N, Matsumura Y, Kataoka K. Development of polymeric micelles for targeting intractable cancers. Cancer Sci. 2016 Jul;107:867–874.
  • Su F, Shen X, Hu YF, et al. Biocompatibility of thermo-responsive PNIPAAm-PLLA-PNIPAAm triblock copolymer as potential drug carrier. Polym Advan Technol. 2015 Dec;26:1567–1574.
  • Jelonek K, Li SM, Wu XH, et al. Self-assembled filomicelles prepared from polylactide/poly(ethylene glycol) block copolymers for anticancer drug delivery. Int J Pharmaceut. 2015 May 15;485:357–364.